Buprenorphine Hydrochloride Tablet
Product Images NDC 0121-1019
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 0121-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Buprenorphine Hydrochloride 2)
Principal Display Panel (2 mg Sublingual Tablet 30-count Bottle Label)
Principal Display Panel (8 mg Sublingual Tablet 30-count Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.